Advertisement

Publications

Kidney360 now discoverable in PMC!

We are proud to announce that Kidney360 has passed the rigorous review process for acceptance into PMC. All content is now available and indexed in PMC.

Submit original research with a trainee as the first author for the 2022 CJASN Trainee of the Year competition.
A prize competition recognizing outstanding work done by junior colleagues.
Acute Kidney Injury and Risk of Nephropathy in Children with Diabetes
Diabetic nephropathy is the leading cause of chronic kidney disease (CKD) in the United States.
Learn how genomic discovery can advance patient care of those with kidney diseases.
Hear new CJASN, JASN and Kidney360 Podcasts
New podcasts added throughout the month
New Articles in the Single Cell Sequencing Methods Collection
Learn about how Single-Nucleus RNA Sequencing Identifies New Classes of Proximal Tubular Epithelial Cells in Kidney Fibrosis

SEVEN MOST RECENTLY PUBLISHED

You have accessRestricted Access
Associations of Anxiety during the COVID-19 Pandemic with Patient Characteristics and Behaviors in CKD Patients: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
Kidney360 May 2022, 10.34067/KID.0000222022; DOI: https://doi.org/10.34067/KID.0000222022
You have accessRestricted Access
Global Dialysis Perspective: Ethiopia
Kidney360 May 2022, 10.34067/KID.0006902021; DOI: https://doi.org/10.34067/KID.0006902021
You have accessRestricted Access
County-Level Dialysis Facility Supply and Distance Traveled to Facilities Among Incident Kidney Failure Patients
Kidney360 May 2022, 10.34067/KID.0000312022; DOI: https://doi.org/10.34067/KID.0000312022
You have accessRestricted Access
Clinical, pathological, and genetic characteristics in patients with focal segmental glomerulosclerosis
Kidney360 May 2022, 10.34067/KID.0000812022; DOI: https://doi.org/10.34067/KID.0000812022
You have accessRestricted Access
Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease
JASN May 2022, ASN.2022020147; DOI: https://doi.org/10.1681/ASN.2022020147
You have accessRestricted Access
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
JASN May 2022, ASN.2022020207; DOI: https://doi.org/10.1681/ASN.2022020207
You have accessRestricted Access
Endothelin Receptor Antagonists for Kidney Protection
CJASN May 2022, CJN.00560122; DOI: https://doi.org/10.2215/CJN.00560122

To access additional Early Access articles, click on the journal name:

CJASN JASN Kidney360

Podcast

CJASN Podcast: Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations

Editorial and Training Opportunities

JASN has a robust Editorial Fellowship program. Learn more about the program: JASN Fellowship
CJASN has a strong Trainee program for first-time first authors. Learn more about the program: CJASN Trainee
The Kidney360 Training Program for early-career nephrologists and scientists is an editorial mentorship program. Learn more at: Training Opportunities